Pancreatic Cancer Research

ResearcherUniversity of CincinnatiActive in the last 2 years

‏Helal F. Hetta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8541-7304; OpenAlex author ID A5066619473. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise. Last author DOI 10.3390/ph18121788↗
  2. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability. Co-author DOI 10.1007/s00261-020-02605-4↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fawaz E. Alanazi · 1 shared paper, 2025 · strength 0.30
  2. Ramy A. Hassan · 1 shared paper, 2021 · strength 0.13
  3. Shimaa Abdalla Ahmed · 1 shared paper, 2021 · strength 0.13
  4. Murad A. Jabir · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.